Your browser doesn't support javascript.
loading
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
Wu, Hao; Esteve, Eduardo; Tremaroli, Valentina; Khan, Muhammad Tanweer; Caesar, Robert; Mannerås-Holm, Louise; Ståhlman, Marcus; Olsson, Lisa M; Serino, Matteo; Planas-Fèlix, Mercè; Xifra, Gemma; Mercader, Josep M; Torrents, David; Burcelin, Rémy; Ricart, Wifredo; Perkins, Rosie; Fernàndez-Real, José Manuel; Bäckhed, Fredrik.
Affiliation
  • Wu H; Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Esteve E; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona, Hospital Josep Trueta, Girona, Spain.
  • Tremaroli V; Departament de Medicina, Facultat de Medicina, University of Girona, Girona, Spain.
  • Khan MT; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Caesar R; Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Mannerås-Holm L; Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Ståhlman M; Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Olsson LM; Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Serino M; Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Planas-Fèlix M; Department of Molecular and Clinical Medicine, Wallenberg Laboratory, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Xifra G; IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France.
  • Mercader JM; Barcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona, Spain.
  • Torrents D; Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació Biomèdica de Girona, Hospital Josep Trueta, Girona, Spain.
  • Burcelin R; Departament de Medicina, Facultat de Medicina, University of Girona, Girona, Spain.
  • Ricart W; Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
  • Perkins R; Barcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona, Spain.
  • Fernàndez-Real JM; Barcelona Supercomputing Center (BSC), Joint BSC-CRG-IRB Research Program in Computational Biology, Barcelona, Spain.
  • Bäckhed F; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Nat Med ; 23(7): 850-858, 2017 Jul.
Article in En | MEDLINE | ID: mdl-28530702
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Bacterial / Diabetes Mellitus, Type 2 / Gastrointestinal Microbiome / Hypoglycemic Agents / Metformin Type of study: Clinical_trials Limits: Animals / Female / Humans / Male / Middle aged Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2017 Document type: Article Affiliation country: Sweden
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA, Bacterial / Diabetes Mellitus, Type 2 / Gastrointestinal Microbiome / Hypoglycemic Agents / Metformin Type of study: Clinical_trials Limits: Animals / Female / Humans / Male / Middle aged Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2017 Document type: Article Affiliation country: Sweden